Merlin@home with the MerlinOnDemand capability Transmitter REF EX1150 Merlin@home with the Mer...
FDA Device Recall #Z-0552-2025 — Class III — October 1, 2024
Recall Summary
| Recall Number | Z-0552-2025 |
| Classification | Class III — Low risk |
| Date Initiated | October 1, 2024 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Abbott Medical |
| Location | Sylmar, CA |
| Product Type | Devices |
| Quantity | Pending |
Product Description
Merlin@home with the MerlinOnDemand capability Transmitter REF EX1150 Merlin@home with the MerlinOnDemand" (MoD) capability is a transmitter configured for multiple patient use. It can receive information from an implantable heart device in unpaired mode. With MoD capability, the transmitter will retrieve full follow-up data or retrieve data for display on the Merlin.net" Patient Care Network (PCN). The MoD capability enables clinicians to do the following: . support remote care patients in emergency rooms and heart failure clinics . triage patients for in clinic follow-ups . support patients in a clinical setting with Merlin.net PCN
Reason for Recall
Due to heart transmitter not being able to upgrade to the current software version in the field after experiencing a power interruption during a prior over-the-wire software download.
Distribution Pattern
Worldwide - U.S. Nationwide distribution in the states of ALABAMA, ALASKA, ARKANSAS, CALIFORNIA, COLORADO, CONNECTICUT, DISTRICT OF COLUMBIA, FLORIDA, GEORGIA, ILLINOIS, INDIANA, KENTUCKY, MICHIGAN, MISSISSIPPI, MISSOURI, MONTANA, NEBRASKA, NEW JERSEY, NEW YORK, NORTH CAROLINA, OHIO, OREGON, PENNSYLVANIA, SOUTH CAROLINA, TENNESSEE, TEXAS, VIRGINIA, WASHINGTON and WISCONSIN. The country of Australia.
Lot / Code Information
Model Number: EX1150 UDI-DI code: Pending Serial Numbers: Pending
Other Recalls from Abbott Medical
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0459-2026 | Class II | Liberta RC DBS IPG (Implantable Pulse Generator... | Oct 6, 2025 |
| Z-0458-2026 | Class II | Eterna SCS IPG (Implantable Pulse Generator), M... | Oct 6, 2025 |
| Z-1557-2025 | Class II | Aveir DR Leadless Pacemaker (LP) Ventricular De... | Feb 15, 2025 |
| Z-0753-2025 | Class II | The Merlin PCS 3650 programmer Model 3330 Th... | Nov 21, 2024 |
| Z-0495-2025 | Class II | Abbott Navitor Transcatheter Aortic Heart Valve... | Oct 17, 2024 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.